세계의 바이오소재 시장 예측(-2032년) : 유형별, 용도별, 지역별 분석

According to Stratistics MRC, the Global Biomaterials Market is accounted for $49.40 billion in 2025 and is expected to reach $92.06 billion by 2032 growing at a CAGR of 9.3% during the forecast period. Biomaterials are natural or synthetic substances designed to interact with biological systems for medical or therapeutic purposes. They can be metals, ceramics, polymers, or composites, carefully engineered to restore, replace, or enhance the function of tissues and organs. Used in applications such as implants, prosthetics, drug delivery systems, and tissue engineering, biomaterials must exhibit biocompatibility, durability, and functionality without causing adverse immune responses. Their design often integrates biology, chemistry, materials science, and engineering to meet specific clinical needs. By bridging technology and biology, biomaterials play a crucial role in advancing modern healthcare, regenerative medicine, and biomedical innovation.

Market Dynamics:

Driver:

Rising prevalence of chronic and cardiovascular diseases

Rising global life expectancy and lifestyle-induced health issues continue to elevate demand for advanced biomaterials. Regenerative therapies and surgical applications benefit significantly from these materials' compatibility and performance. Minimally invasive procedures further drive utilization across clinical settings. Expanding healthcare needs are reinforcing the strategic importance of biomaterials. Long-term market growth is being shaped by these evolving medical requirements.

Restraint:

Stringent regulatory and clinical approval processes

Medical-grade materials must meet rigorous safety and performance standards. Approval cycles are lengthy and vary across jurisdictions, increasing compliance costs. These challenges slow down innovation and delay commercialization. Smaller firms may find it difficult to navigate these requirements. Regulatory fragmentation continues to restrict rapid market expansion.

Opportunity:

Growing adoption of implantable medical devices

Integration with human tissue demands biomaterials that exhibit high biocompatibility and structural reliability. Applications span orthopedic implants, cardiovascular stents, dental restorations, and neuroprosthetic interfaces. Continuous advancements in material engineering are enhancing durability, functionality, and patient outcomes. Preference for minimally invasive and long-lasting medical solutions is rising across global healthcare systems. Adoption trends are accelerating innovation cycles within the biomaterials sector.

Threat:

High R&D and production costs

Developing safe and effective materials requires substantial investment in research, testing, and regulatory compliance. Production processes are often specialized and capital-intensive. Smaller players may struggle to compete with established firms. These cost pressures slow product development and market penetration. Economic barriers remain a persistent threat to growth.

Covid-19 Impact:

The Covid-19 pandemic had a mixed impact on the biomaterials market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced elective medical procedures hindered demand. Hospitals prioritized emergency care, delaying surgeries involving implants and prosthetics. However, the pandemic also accelerated the use of biomaterials in medical devices, diagnostics, and personal protective equipment. Increased investments in healthcare infrastructure and research further supported market recovery. Post-pandemic, rising focus on advanced healthcare solutions and regenerative medicine boosted demand for biomaterials.

The polymeric biomaterials segment is expected to be the largest during the forecast period

The polymeric biomaterials segment is expected to account for the largest market share during the forecast period due to their adaptability and broad clinical utility. These materials are widely used in cardiovascular, orthopedic, and wound care applications. Their flexibility, biocompatibility, and ease of customization make them ideal for diverse medical needs. Innovations in biodegradable and drug-releasing polymers are expanding their scope. They also support minimally invasive treatment approaches. This segment will continue to lead in both volume and innovation.

The ophthalmology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ophthalmology segment is predicted to witness the highest growth rate increasing demand for precision eye care solutions. Biomaterials are being used in intraocular lenses, corneal scaffolds, and ocular drug delivery systems. Aging populations and rising cases of vision impairment are fuelling adoption. Transparent and biocompatible materials are improving surgical outcomes. Minimally invasive ophthalmic procedures are gaining traction globally. This segment is poised for rapid expansion in the coming years.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share by high adoption of innovative medical technologies, and strong research and development activities. The region shows widespread use of biomaterials in orthopedics, cardiovascular devices, wound healing, and cosmetic surgery. Strategic collaborations between universities, research institutions, and biotech firms foster innovation and product development. Established industry players, favorable regulatory policies, and the rising preference for minimally invasive treatments collectively fuel market expansion. Growing awareness about personalized healthcare and regenerative medicine also strengthens the market landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rapid urbanization, an expanding healthcare infrastructure, and growing investments in advanced medical technologies. Increasing prevalence of chronic diseases and rising demand for orthopedic, cardiovascular, and dental implants further support market growth. Countries such as China, India, and Japan play a significant role due to large patient populations and improving healthcare access. Additionally, government initiatives promoting research and local production of biomaterials encourage innovation, making the region a hotspot for future market expansion and development.

Key players in the market

Some of the key players in Biomaterials Market include BASF SE, Evonik Industries AG, Corbion N.V., Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Victrex plc, Zimmer Biomet, Johnson & Johnson, Medtronic plc, Stryker Corporation, DSM-Firmenich, Noble Biomaterials Inc., CoorsTek Inc. and CeramTec GmbH.

Key Developments:

In July 2025, BASF signed a global framework agreement with CATL to supply advanced cathode active materials for lithium-ion batteries. While focused on energy storage, the partnership leverages BASF's biomaterials expertise in sustainable sourcing and circular chemistry to support CATL's green transformation goals.

In January 2025, Evonik formed a joint venture with Fuhua Tongda Chemical Co., Ltd. in Sichuan, China, to produce specialty hydrogen peroxide for medical and semiconductor applications. The venture builds on a prior licensing agreement and supports Evonik's biomaterials strategy by securing sustainable raw materials for high-purity processing.

Types Covered:

• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials
• Natural Biomaterials
• Other Types

Applications Covered:

• Cardiovascular
• Orthopedic
• Ophthalmology
• Dental
• Wound Healing
• Wound Healing
• Neurology
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Biomaterials Market, By Type

• 5.1 Introduction
• 5.2 Metallic Biomaterials
  • 5.2.1 Stainless Steel
  • 5.2.2 Titanium & Titanium Alloys
  • 5.2.3 Cobalt-Chromium Alloys
• 5.3 Polymeric Biomaterials
  • 5.3.1 Polymethyl Methacrylate (PMMA)
  • 5.3.2 Polyethylene (PE)
  • 5.3.3 Polypropylene (PP)
  • 5.3.4 Polyvinyl Chloride (PVC)
  • 5.3.5 Silicone
• 5.4 Ceramic Biomaterials
  • 5.4.1 Alumina
  • 5.4.2 Zirconia
  • 5.4.3 Calcium Phosphates
• 5.5 Natural Biomaterials
  • 5.5.1 Collagen
  • 5.5.2 Gelatin
  • 5.5.3 Chitosan
  • 5.5.4 Alginate
  • 5.5.5 Silk
  • 5.5.6 Hyaluronic Acid
• 5.6 Other Types

6 Global Biomaterials Market, By Application

• 6.1 Introduction
• 6.2 Cardiovascular
  • 6.2.1 Stents & Grafts
  • 6.2.2 Heart Valves
  • 6.2.3 Pacemakers & Implantable Devices
• 6.3 Orthopedic
  • 6.3.1 Joint Replacement
  • 6.3.2 Bone Plates & Screws
  • 6.3.3 Spinal Implants
• 6.4 Ophthalmology
  • 6.4.1 Contact Lenses
  • 6.4.2 Intraocular Lenses
  • 6.4.3 Corneal Implants
• 6.5 Dental
  • 6.5.1 Dental Implants
  • 6.5.2 Crowns & Bridges
  • 6.5.3 Dentures
• 6.6 Wound Healing
  • 6.6.1 Surgical Sutures
  • 6.6.2 Tissue Sealants & Adhesives
  • 6.6.3 Dressings
• 6.7 Neurology
  • 6.7.1 Neural Implants
  • 6.7.2 Shunts
  • 6.7.3 Electrodes
• 6.8 Other Applications

7 Global Biomaterials Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 BASF SE
• 9.2 Evonik Industries AG
• 9.3 Corbion N.V.
• 9.4 Covestro AG
• 9.5 Celanese Corporation
• 9.6 Carpenter Technology Corporation
• 9.7 Victrex plc
• 9.8 Zimmer Biomet
• 9.9 Johnson & Johnson
• 9.10 Medtronic plc
• 9.11 Stryker Corporation
• 9.12 DSM-Firmenich
• 9.13 Noble Biomaterials Inc.
• 9.14 CoorsTek Inc.
• 9.15 CeramTec GmbH